These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19337828)
1. Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines. Chakraborty AK; Welsh A; Digiovanna MP Breast Cancer Res Treat; 2010 Apr; 120(2):327-35. PubMed ID: 19337828 [TBL] [Abstract][Full Text] [Related]
2. Co-targeting insulin-like growth factor I receptor and HER2: dramatic effects of HER2 inhibitors on nonoverexpressing breast cancer. Chakraborty AK; Liang K; DiGiovanna MP Cancer Res; 2008 Mar; 68(5):1538-45. PubMed ID: 18316619 [TBL] [Abstract][Full Text] [Related]
3. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306 [TBL] [Abstract][Full Text] [Related]
4. Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells. Riedemann J; Sohail M; Macaulay VM Biochem Biophys Res Commun; 2007 Apr; 355(3):700-6. PubMed ID: 17320820 [TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt. Yeh J; Litz J; Hauck P; Ludwig DL; Krystal GW Lung Cancer; 2008 May; 60(2):166-74. PubMed ID: 18006183 [TBL] [Abstract][Full Text] [Related]
6. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways. Chen J; Power KA; Mann J; Cheng A; Thompson LU Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin. Zhang H; Pelzer AM; Kiang DT; Yee D Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722 [TBL] [Abstract][Full Text] [Related]
8. Co-targeting ER and HER family receptors induces apoptosis in HER2-normal or overexpressing breast cancer models. Chakraborty AK; Mehra R; Digiovanna MP Anticancer Res; 2015 Mar; 35(3):1243-50. PubMed ID: 25750271 [TBL] [Abstract][Full Text] [Related]
9. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53. Niu J; Xu Z; Li XN; Han Z Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer. Kurokawa H; Arteaga CL Clin Cancer Res; 2001 Dec; 7(12 Suppl):4436s-4442s; discussion 4411s-4412s. PubMed ID: 11916237 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer. Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells. Hodges-Gallagher L; Valentine CD; Bader SE; Kushner PJ Breast Cancer Res Treat; 2007 Nov; 105(3):297-309. PubMed ID: 17186358 [TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872 [TBL] [Abstract][Full Text] [Related]
14. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Chen J; Power KA; Mann J; Cheng A; Thompson LU Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953 [TBL] [Abstract][Full Text] [Related]
15. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells. Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281 [TBL] [Abstract][Full Text] [Related]
16. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells. Youngren JF; Gable K; Penaranda C; Maddux BA; Zavodovskaya M; Lobo M; Campbell M; Kerner J; Goldfine ID Breast Cancer Res Treat; 2005 Nov; 94(1):37-46. PubMed ID: 16142439 [TBL] [Abstract][Full Text] [Related]
17. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches. Hoffmann J; Sommer A J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262 [TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Hodges-Gallagher L; Valentine CD; El Bader S; Kushner PJ Breast Cancer Res Treat; 2008 May; 109(2):241-50. PubMed ID: 17638070 [TBL] [Abstract][Full Text] [Related]
19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
20. A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study. Martins AS; Ordoñez JL; García-Sánchez A; Herrero D; Sevillano V; Osuna D; Mackintosh C; Caballero G; Otero AP; Poremba C; Madoz-Gúrpide J; de Alava E Cancer Res; 2008 Aug; 68(15):6260-70. PubMed ID: 18676850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]